SOST and chronic myelogenous leukemia, BCR-ABL1 positive: SOST expression in CML-treated osteocytes was (0.74, 95% CI: 0.39 - 1.09, p = 0.52), similar to that in OC (0.96, 95% CI: 0.51 - 1.41).